Corporate
Anika Therapeutics CEO Blanchard Steps Down After Turbulent 6-Year Tenure; CFO Griffin Takes Helm
Jan 8
You're signed outSign in or to get full access.
AT
Anika Therapeutics (ANIK)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Anika Therapeutics.